| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.10e-06 | 37 | 186 | 6 | GO:0045505 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.01e-05 | 18 | 186 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | protein kinase activity | ERBB4 KALRN NEK10 MARK3 MINK1 SIK1 TRIM24 BCR TTK MAP3K1 CSF1R BRAF PIK3C3 PRKACG IRAK3 MAP3K15 MARK2 | 4.85e-05 | 600 | 186 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | calcium ion binding | FAT4 CABP2 DSG3 PCDH11Y DGKG DYSF PPEF1 DNAH7 PCDH17 ITPR3 MYOF EFHC1 BRAF FER1L5 AGRN CDH7 CDH17 CDH18 MASP2 | 7.63e-05 | 749 | 186 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | kinase activity | ERBB4 KALRN NEK10 MARK3 MINK1 DGKG SIK1 TRIM24 BCR TTK MAP3K1 CSF1R BRAF PIK3C3 PRKACG ALDH18A1 IRAK3 MAP3K15 MARK2 | 9.89e-05 | 764 | 186 | 19 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | ERBB4 KALRN NEK10 MARK3 MINK1 DGKG SIK1 TRIM24 BCR TTK MAP3K1 CSF1R BRAF PIK3C3 PRKACG IRAK3 MAP3K15 MARK2 | 1.17e-04 | 709 | 186 | 18 | GO:0016773 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.25e-04 | 28 | 186 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | KALRN NEK10 MARK3 MINK1 SIK1 BCR TTK MAP3K1 BRAF PRKACG MAP3K15 MARK2 | 1.60e-04 | 363 | 186 | 12 | GO:0106310 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERBB4 KALRN NEK10 MARK3 MINK1 DGKG SIK1 PIGG TRIM24 BCR TTK MAP3K1 CSF1R BRAF PIK3C3 PARP16 PRKACG ALDH18A1 IRAK3 MAP3K15 MARK2 | 1.83e-04 | 938 | 186 | 21 | GO:0016772 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | KALRN NEK10 MARK3 MINK1 SIK1 BCR TTK MAP3K1 BRAF PRKACG IRAK3 MAP3K15 MARK2 | 2.92e-04 | 446 | 186 | 13 | GO:0004674 |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | CATSPERE SPEM3 TTC21A DNAH2 DNAH7 DNAAF2 EFHC1 DNAH12 GAS2L2 POC1B VPS13A CFAP70 DNAH11 | 9.25e-08 | 215 | 188 | 13 | GO:0060285 |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | CATSPERE SPEM3 TTC21A DNAH2 DNAH7 DNAAF2 EFHC1 DNAH12 GAS2L2 POC1B VPS13A CFAP70 DNAH11 | 9.25e-08 | 215 | 188 | 13 | GO:0001539 |
| GeneOntologyBiologicalProcess | cilium movement | CATSPERE SPEM3 NEK10 TTC21A DNAH2 DNAH7 DNAAF2 DNAH12 GAS2L2 POC1B VPS13A KATNIP CFAP70 DNAH11 | 1.29e-07 | 261 | 188 | 14 | GO:0003341 |
| GeneOntologyBiologicalProcess | microtubule-based process | DYNLT2B CATSPERE SPEM3 MCPH1 PRICKLE1 IFT57 NEK10 TTC21A DNAH2 DYSF TTK DNAH7 CEP350 DNAAF2 EFHC1 DNAH12 GAS2L2 POC1B VPS13A KATNIP RP1 CFAP70 MARK2 PARD3 ESPL1 AGRN DNAH11 | 1.25e-06 | 1058 | 188 | 27 | GO:0007017 |
| GeneOntologyBiologicalProcess | negative regulation of T cell cytokine production | 3.13e-06 | 12 | 188 | 4 | GO:0002725 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | CATSPERE SPEM3 TTC21A DNAH2 DNAH7 DNAH12 GAS2L2 POC1B VPS13A CFAP70 DNAH11 | 3.75e-06 | 210 | 188 | 11 | GO:0060294 |
| GeneOntologyBiologicalProcess | negative regulation of production of molecular mediator of immune response | 1.18e-05 | 56 | 188 | 6 | GO:0002701 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | DYNLT2B CATSPERE SPEM3 IFT57 NEK10 TTC21A DNAH2 DNAH7 DNAAF2 DNAH12 GAS2L2 POC1B VPS13A KATNIP CFAP70 DNAH11 | 1.24e-05 | 493 | 188 | 16 | GO:0007018 |
| GeneOntologyBiologicalProcess | negative regulation of cytokine production involved in immune response | 2.67e-05 | 39 | 188 | 5 | GO:0002719 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response | 4.64e-05 | 71 | 188 | 6 | GO:0002820 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 4.80e-05 | 228 | 188 | 10 | GO:0046777 | |
| GeneOntologyBiologicalProcess | T-tubule organization | 6.01e-05 | 9 | 188 | 3 | GO:0033292 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response | 7.13e-05 | 239 | 188 | 10 | GO:0050777 | |
| GeneOntologyBiologicalProcess | monocyte activation involved in immune response | 8.26e-05 | 2 | 188 | 2 | GO:0002280 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | CHL1 HGF RAPH1 KALRN PRICKLE1 MINK1 SH3GL2 RTN4RL1 LAMC2 MAP3K1 COL18A1 FRY CSF1R BRAF HPN POC1B VPS13A RIMS1 CFAP70 MARK2 PARD3 AGRN CDH7 CDH17 CDH18 | 8.88e-05 | 1194 | 188 | 25 | GO:0000902 |
| GeneOntologyBiologicalProcess | immune effector process | DOCK2 MYO1G HFE IL31RA TBX21 SHB GAPT CHGA DYSF BCR ARG1 NOD1 CD74 IRAK3 FER1L5 IL4R CDH17 MASP2 SMAD7 SPINK5 | 1.18e-04 | 859 | 188 | 20 | GO:0002252 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | DOCK2 HFE HGF EPS8L2 KALRN ENTR1 IQSEC2 SH3GL2 IRX3 BCR MAP3K1 PLEK2 MAGI2 NEU1 BRAF PAN2 PARN RP1 RIMS1 MARK2 PARD3 ESPL1 OGA AGRN IL4R ALOX15 CDH17 | 1.19e-04 | 1366 | 188 | 27 | GO:0051130 |
| GeneOntologyBiologicalProcess | T cell cytokine production | 1.20e-04 | 53 | 188 | 5 | GO:0002369 | |
| GeneOntologyBiologicalProcess | leukocyte activation involved in immune response | DOCK2 TBX21 SHB GAPT CHGA DYSF BCR CD74 FER1L5 IL4R CDH17 SMAD7 | 1.24e-04 | 361 | 188 | 12 | GO:0002366 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CHL1 HFE FAT4 DSG3 PRICKLE1 MINK1 TBX21 PCDH11Y SHB FNDC3A CD83 PCDH17 ARG1 MAGI2 CD74 PARD3 CDH7 IL4R ALOX15 CDH17 CDH18 SMAD7 PEAR1 | 1.30e-04 | 1077 | 188 | 23 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell activation involved in immune response | DOCK2 TBX21 SHB GAPT CHGA DYSF BCR CD74 FER1L5 IL4R CDH17 SMAD7 | 1.38e-04 | 365 | 188 | 12 | GO:0002263 |
| GeneOntologyBiologicalProcess | type 2 immune response | 1.43e-04 | 55 | 188 | 5 | GO:0042092 | |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 1.45e-04 | 166 | 188 | 8 | GO:0002698 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | ERBB4 MCPH1 MCM8 KALRN PRICKLE1 MARK3 TTC21A ENTR1 IQSEC2 NUP98 BRME1 DAXX DTX3L CHGA TTK CEP350 MAGI2 GAS2L2 UBR5 PIK3C3 VPS13A VCPIP1 DNAH11 | 1.57e-04 | 1091 | 188 | 23 | GO:0033365 |
| GeneOntologyBiologicalProcess | cytokine production involved in immune response | 1.58e-04 | 168 | 188 | 8 | GO:0002367 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell mediated immunity | 2.50e-04 | 34 | 188 | 4 | GO:0002710 | |
| GeneOntologyBiologicalProcess | negative thymic T cell selection | 2.52e-04 | 14 | 188 | 3 | GO:0045060 | |
| GeneOntologyBiologicalProcess | neuron projection development | CHL1 HGF FAT4 RAPH1 KALRN PRICKLE1 ZNF212 MINK1 SH3GL2 DGKG RTN4RL1 LAMC2 UPF3B CSMD3 MAGI2 FRY NEU1 CSF1R BRAF VPS13A MTR RIMS1 MARK2 PARD3 AGRN | 2.76e-04 | 1285 | 188 | 25 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of production of molecular mediator of immune response | 2.79e-04 | 231 | 188 | 9 | GO:0002700 | |
| GeneOntologyBiologicalProcess | negative T cell selection | 3.13e-04 | 15 | 188 | 3 | GO:0043383 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 3.27e-04 | 187 | 188 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3.40e-04 | 66 | 188 | 5 | GO:0002823 | |
| GeneOntologyBiologicalProcess | regulation of type 2 immune response | 3.49e-04 | 37 | 188 | 4 | GO:0002828 | |
| GeneOntologyBiologicalProcess | regulation of cytokine production involved in immune response | 3.75e-04 | 145 | 188 | 7 | GO:0002718 | |
| GeneOntologyBiologicalProcess | T cell selection | 4.18e-04 | 69 | 188 | 5 | GO:0045058 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | DYNLT2B EPS8L2 PRICKLE1 IFT57 ENTR1 MINK1 DNAH2 DNAH7 CEP350 PLEK2 DNAAF2 PTPDC1 POC1B RP1 CFAP70 AGRN | 4.40e-04 | 670 | 188 | 16 | GO:0120031 |
| GeneOntologyBiologicalProcess | cilium organization | DYNLT2B PRICKLE1 IFT57 TTC21A ENTR1 DNAH2 DNAH7 CEP350 DNAAF2 PTPDC1 POC1B RP1 CFAP70 | 4.43e-04 | 476 | 188 | 13 | GO:0044782 |
| GeneOntologyBiologicalProcess | inner dynein arm assembly | 4.61e-04 | 17 | 188 | 3 | GO:0036159 | |
| GeneOntologyBiologicalProcess | specification of loop of Henle identity | 4.90e-04 | 4 | 188 | 2 | GO:0072086 | |
| GeneOntologyBiologicalProcess | negative regulation of T-helper 2 cell cytokine production | 4.90e-04 | 4 | 188 | 2 | GO:2000552 | |
| GeneOntologyBiologicalProcess | regulation of T cell cytokine production | 5.20e-04 | 41 | 188 | 4 | GO:0002724 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell differentiation | 5.43e-04 | 73 | 188 | 5 | GO:0043370 | |
| GeneOntologyBiologicalProcess | cell projection assembly | DYNLT2B EPS8L2 PRICKLE1 IFT57 ENTR1 MINK1 DNAH2 DNAH7 CEP350 PLEK2 DNAAF2 PTPDC1 POC1B RP1 CFAP70 AGRN | 5.59e-04 | 685 | 188 | 16 | GO:0030031 |
| GeneOntologyCellularComponent | axoneme | DYNLT2B IFT57 DNAH2 DNAH7 SPTBN5 EFHC1 DNAH12 PIK3C3 RP1 CFAP70 DNAH11 | 2.73e-06 | 207 | 187 | 11 | GO:0005930 |
| GeneOntologyCellularComponent | ciliary plasm | DYNLT2B IFT57 DNAH2 DNAH7 SPTBN5 EFHC1 DNAH12 PIK3C3 RP1 CFAP70 DNAH11 | 2.87e-06 | 208 | 187 | 11 | GO:0097014 |
| GeneOntologyCellularComponent | cytoplasmic region | DYNLT2B IFT57 IQSEC2 DNAH2 DNAH7 SPTBN5 EFHC1 DNAH12 PIK3C3 RP1 RIMS1 CFAP70 MARK2 DNAH11 | 4.76e-06 | 360 | 187 | 14 | GO:0099568 |
| GeneOntologyCellularComponent | microtubule organizing center | HORMAD2 DYNLT2B EPS8L2 MCPH1 IFT57 ENTR1 ANKS1B UPF3B SPPL2B DYSF TRIP4 CEP350 DNAAF2 MAGI2 MYOF FRY EFHC1 GAS2L2 POC1B CFAP70 ESPL1 IL4R SMAD7 | 8.38e-06 | 919 | 187 | 23 | GO:0005815 |
| GeneOntologyCellularComponent | dynein complex | 8.55e-06 | 54 | 187 | 6 | GO:0030286 | |
| GeneOntologyCellularComponent | centrosome | HORMAD2 DYNLT2B EPS8L2 MCPH1 IFT57 ENTR1 ANKS1B UPF3B SPPL2B DYSF TRIP4 CEP350 MAGI2 MYOF FRY EFHC1 POC1B ESPL1 IL4R SMAD7 | 2.00e-05 | 770 | 187 | 20 | GO:0005813 |
| GeneOntologyCellularComponent | cilium | DYNLT2B CATSPERE IFT57 TTC21A ENTR1 PCDH11Y DNAH2 DNAH7 DNAAF2 SPTBN5 MAGI2 EFHC1 DNAH12 GAS2L2 PIK3C3 POC1B VPS13A PRKACG RP1 CFAP70 DNAH11 | 5.69e-05 | 898 | 187 | 21 | GO:0005929 |
| GeneOntologyCellularComponent | axonemal dynein complex | 6.77e-05 | 25 | 187 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | inner dynein arm | 8.07e-05 | 10 | 187 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.03e-04 | 161 | 187 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | DYNLT2B IFT57 DNAH2 DNAH7 SPTBN5 EFHC1 DNAH12 PIK3C3 RP1 CFAP70 DNAH11 | 1.40e-04 | 317 | 187 | 11 | GO:0032838 |
| GeneOntologyCellularComponent | cell cortex region | 6.94e-04 | 45 | 187 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.40e-03 | 238 | 187 | 8 | GO:0097729 | |
| GeneOntologyCellularComponent | ciliary base | 1.58e-03 | 56 | 187 | 4 | GO:0097546 | |
| MousePheno | enlarged brain ventricles | CHL1 HFE PRICKLE1 DNAAF2 COL18A1 EFHC1 CSF1R KATNIP CFAP70 HSF2 | 1.22e-05 | 156 | 160 | 10 | MP:0011380 |
| MousePheno | abnormal brain ventricle size | CHL1 HFE PRICKLE1 DNAAF2 COL18A1 EFHC1 CSF1R KATNIP CFAP70 HSF2 | 1.89e-05 | 164 | 160 | 10 | MP:0013229 |
| Domain | FerA | 1.00e-06 | 3 | 188 | 3 | SM01200 | |
| Domain | Ferlin_A-domain | 1.00e-06 | 3 | 188 | 3 | IPR012560 | |
| Domain | FerA | 1.00e-06 | 3 | 188 | 3 | PF08165 | |
| Domain | DysFC | 3.99e-06 | 4 | 188 | 3 | SM00694 | |
| Domain | DysFN | 3.99e-06 | 4 | 188 | 3 | SM00693 | |
| Domain | Peroxin/Ferlin | 3.99e-06 | 4 | 188 | 3 | IPR006614 | |
| Domain | Dynein_heavy_chain_D4_dom | 9.20e-06 | 14 | 188 | 4 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 9.20e-06 | 14 | 188 | 4 | IPR013602 | |
| Domain | DHC_N2 | 9.20e-06 | 14 | 188 | 4 | PF08393 | |
| Domain | AAA_8 | 9.20e-06 | 14 | 188 | 4 | PF12780 | |
| Domain | FerI | 9.89e-06 | 5 | 188 | 3 | SM01202 | |
| Domain | FerB | 9.89e-06 | 5 | 188 | 3 | SM01201 | |
| Domain | Ferlin_B-domain | 9.89e-06 | 5 | 188 | 3 | IPR012561 | |
| Domain | Ferlin_C | 9.89e-06 | 5 | 188 | 3 | PF16165 | |
| Domain | Ferlin_C | 9.89e-06 | 5 | 188 | 3 | IPR032362 | |
| Domain | FerIin_dom | 9.89e-06 | 5 | 188 | 3 | IPR012968 | |
| Domain | FerI | 9.89e-06 | 5 | 188 | 3 | PF08151 | |
| Domain | FerB | 9.89e-06 | 5 | 188 | 3 | PF08150 | |
| Domain | DHC_fam | 1.24e-05 | 15 | 188 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 1.24e-05 | 15 | 188 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.24e-05 | 15 | 188 | 4 | IPR004273 | |
| Domain | Kinase-like_dom | ERBB4 RAPH1 KALRN NEK10 MARK3 MINK1 SIK1 TTK MAP3K1 PTPN13 CSF1R BRAF PIK3C3 PRKACG IRAK3 MAP3K15 MARK2 | 3.57e-05 | 542 | 188 | 17 | IPR011009 |
| Domain | Cadherin_CS | 1.17e-04 | 109 | 188 | 7 | IPR020894 | |
| Domain | Protein_kinase_ATP_BS | ERBB4 KALRN NEK10 MARK3 MINK1 SIK1 TTK MAP3K1 CSF1R BRAF PRKACG MAP3K15 MARK2 | 1.27e-04 | 379 | 188 | 13 | IPR017441 |
| Domain | - | 1.29e-04 | 148 | 188 | 8 | 2.60.40.150 | |
| Domain | CADHERIN_1 | 1.47e-04 | 113 | 188 | 7 | PS00232 | |
| Domain | Cadherin | 1.47e-04 | 113 | 188 | 7 | PF00028 | |
| Domain | CADHERIN_2 | 1.56e-04 | 114 | 188 | 7 | PS50268 | |
| Domain | - | 1.56e-04 | 114 | 188 | 7 | 2.60.40.60 | |
| Domain | CA | 1.64e-04 | 115 | 188 | 7 | SM00112 | |
| Domain | Cadherin-like | 1.73e-04 | 116 | 188 | 7 | IPR015919 | |
| Domain | Cadherin | 1.93e-04 | 118 | 188 | 7 | IPR002126 | |
| Domain | UBA | 2.22e-04 | 30 | 188 | 4 | SM00165 | |
| Domain | PROTEIN_KINASE_ATP | ERBB4 KALRN NEK10 MARK3 MINK1 SIK1 TTK MAP3K1 CSF1R BRAF PRKACG IRAK3 MAP3K15 MARK2 | 2.37e-04 | 459 | 188 | 14 | PS00107 |
| Domain | C2_dom | 2.61e-04 | 164 | 188 | 8 | IPR000008 | |
| Domain | Dynein_HC_stalk | 3.37e-04 | 14 | 188 | 3 | IPR024743 | |
| Domain | ATPase_dyneun-rel_AAA | 3.37e-04 | 14 | 188 | 3 | IPR011704 | |
| Domain | MT | 3.37e-04 | 14 | 188 | 3 | PF12777 | |
| Domain | AAA_5 | 3.37e-04 | 14 | 188 | 3 | PF07728 | |
| Domain | Prot_kinase_dom | ERBB4 KALRN NEK10 MARK3 MINK1 SIK1 TTK MAP3K1 CSF1R BRAF PRKACG IRAK3 MAP3K15 MARK2 | 4.48e-04 | 489 | 188 | 14 | IPR000719 |
| Domain | C2 | 4.79e-04 | 137 | 188 | 7 | SM00239 | |
| Domain | PROTEIN_KINASE_DOM | ERBB4 KALRN NEK10 MARK3 MINK1 SIK1 TTK MAP3K1 CSF1R BRAF PRKACG IRAK3 MAP3K15 MARK2 | 4.85e-04 | 493 | 188 | 14 | PS50011 |
| Domain | Pkinase | KALRN NEK10 MARK3 MINK1 SIK1 TTK MAP3K1 BRAF PRKACG IRAK3 MAP3K15 MARK2 | 4.98e-04 | 381 | 188 | 12 | PF00069 |
| Domain | C2 | 5.94e-04 | 142 | 188 | 7 | PS50004 | |
| Domain | MARK/par1 | 5.97e-04 | 4 | 188 | 2 | IPR033624 | |
| Domain | - | EPS8L2 RASA2 RAPH1 KALRN SH3BP2 IQSEC2 ANKS1B BCR NECAP1 PLEK2 SPTBN5 PTPN13 | 6.25e-04 | 391 | 188 | 12 | 2.30.29.30 |
| Domain | AAA | 6.45e-04 | 144 | 188 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 6.45e-04 | 144 | 188 | 7 | IPR003593 | |
| Domain | UBA | 9.85e-04 | 44 | 188 | 4 | IPR015940 | |
| Domain | KA1 | 9.88e-04 | 5 | 188 | 2 | PF02149 | |
| Domain | KA1_dom | 9.88e-04 | 5 | 188 | 2 | IPR001772 | |
| Domain | KA1 | 9.88e-04 | 5 | 188 | 2 | PS50032 | |
| Domain | - | 9.88e-04 | 5 | 188 | 2 | 3.30.310.80 | |
| Domain | Ser/Thr_kinase_AS | KALRN MARK3 MINK1 SIK1 TTK MAP3K1 BRAF PRKACG IRAK3 MAP3K15 MARK2 | 1.02e-03 | 357 | 188 | 11 | IPR008271 |
| Domain | S_TKc | KALRN NEK10 MARK3 MINK1 SIK1 TTK MAP3K1 BRAF PRKACG MAP3K15 MARK2 | 1.06e-03 | 359 | 188 | 11 | SM00220 |
| Domain | PROTEIN_KINASE_ST | KALRN MARK3 MINK1 SIK1 TTK MAP3K1 BRAF PRKACG IRAK3 MAP3K15 MARK2 | 1.14e-03 | 362 | 188 | 11 | PS00108 |
| Domain | UBA | 1.26e-03 | 47 | 188 | 4 | PS50030 | |
| Domain | PH_dom-like | EPS8L2 RASA2 RAPH1 KALRN SH3BP2 IQSEC2 ANKS1B BCR NECAP1 PLEK2 SPTBN5 PTPN13 | 1.31e-03 | 426 | 188 | 12 | IPR011993 |
| Domain | IRO | 1.47e-03 | 6 | 188 | 2 | SM00548 | |
| Domain | Iroquois_homeo | 1.47e-03 | 6 | 188 | 2 | IPR003893 | |
| Domain | PET | 1.47e-03 | 6 | 188 | 2 | PF06297 | |
| Domain | PET_domain | 1.47e-03 | 6 | 188 | 2 | IPR010442 | |
| Domain | PET | 1.47e-03 | 6 | 188 | 2 | PS51303 | |
| Domain | Cadherin_C | 1.96e-03 | 25 | 188 | 3 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 1.96e-03 | 25 | 188 | 3 | IPR000233 | |
| Domain | KA1/Ssp2_C | 2.05e-03 | 7 | 188 | 2 | IPR028375 | |
| Domain | C2 | 2.12e-03 | 131 | 188 | 6 | PF00168 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AMPD2 ERBB4 TCF20 RAPH1 MARK3 IQSEC2 MINK1 SIK1 BCR TTK DNAH7 CEP350 PTPN13 BRAF PIK3C3 PRRC2C SRGAP1 NHS MARK2 PARD3 VCPIP1 | 1.26e-08 | 861 | 190 | 21 | 36931259 |
| Pubmed | FAT4 TCF20 RASA2 PRICKLE1 TRPS1 DNAH2 MORC4 TRIM24 DNAH7 ITPR3 CEP350 DNAH12 VPS13A IRAK3 MRPL41 FER1L5 CDH17 DNAH11 | 1.66e-08 | 638 | 190 | 18 | 31182584 | |
| Pubmed | HDAC5 TCF20 RAPH1 TRPS1 MECOM MORC4 TRIM24 BCR PTPN13 GTF2I ZFHX4 UBR5 ZBTB11 VCPIP1 | 8.73e-08 | 418 | 190 | 14 | 34709266 | |
| Pubmed | HDAC5 LRCH2 IFT57 ENTR1 UPF3B BCR TTK CEP350 TDRD3 PIK3C3 BOP1 | 1.55e-07 | 251 | 190 | 11 | 29778605 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DYNLT2B MCPH1 MCM8 RASA2 MARK3 TTC21A SH3BP2 MINK1 PCDH11Y TRPS1 SHB RTN4RL1 SPPL2B BCR EVA1C COL18A1 PTPDC1 PTPN13 GTF2I PIK3C3 HPN ENPP5 KATNIP RIMS1 PARD3 ARHGAP8 | 1.80e-07 | 1489 | 190 | 26 | 28611215 |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | ERBB4 IL16 NUP98 IRX3 IRX1 TG MAGI2 PTPN13 IFI30 RIMS1 PARD3 | 2.67e-07 | 265 | 190 | 11 | 19240061 |
| Pubmed | 8.28e-07 | 14 | 190 | 4 | 9373155 | ||
| Pubmed | AMPD2 TCF20 LRCH2 KALRN IQSEC2 MINK1 SH3GL2 ANKS1B CNRIP1 BCR MAGI2 TDRD3 FRY UBR5 PRRC2C PARN RIMS1 PARD3 AGRN | 1.59e-06 | 963 | 190 | 19 | 28671696 | |
| Pubmed | 2.47e-06 | 209 | 190 | 9 | 36779422 | ||
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 16980613 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | EPS8L2 HDAC5 MCM8 RAPH1 SH3BP2 ENTR1 IQSEC2 COPB2 SIK1 DAXX UPF3B BCR TRIP4 MAP3K1 CEP350 PTPDC1 UBR5 KATNIP ESPL1 | 4.71e-06 | 1038 | 190 | 19 | 26673895 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | HDAC5 ENTR1 MECOM DAXX UPF3B MORC4 BCR TTK TDRD3 UBR5 PRRC2C MTR HSF2 VCPIP1 | 4.94e-06 | 588 | 190 | 14 | 38580884 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DYNLT2B TES LRCH2 RAPH1 ENTR1 SH3GL2 SHB ANKLE2 BCR TTK DNAH7 CEP350 IARS2 UBR5 MRPL41 AGRN VCPIP1 | 5.07e-06 | 853 | 190 | 17 | 28718761 |
| Pubmed | 5.53e-06 | 7 | 190 | 3 | 9256245 | ||
| Pubmed | DOCK2 MYO1G HGF FNDC3A PIGG ANKLE2 BCR TTK ITPR3 CEP350 GTF2I MIA2 UBR5 PIK3C3 PARP16 PRRC2C FURIN CD74 DDX3Y OGA | 7.00e-06 | 1168 | 190 | 20 | 19946888 | |
| Pubmed | AMPD2 HDAC5 LRCH2 MARK3 ENTR1 R3HDM2 PTPN13 BRAF UBR5 ALDH18A1 MARK2 PARD3 | 7.09e-06 | 446 | 190 | 12 | 24255178 | |
| Pubmed | 8.11e-06 | 242 | 190 | 9 | 34011540 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 8.43e-06 | 184 | 190 | 8 | 32908313 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MINK1 COPB2 DAXX DYSF BCR TTK TRIP4 NECAP1 CEP350 MYOF TDRD3 PTPN13 PRRC2C BOP1 ESPL1 | 1.18e-05 | 724 | 190 | 15 | 36232890 |
| Pubmed | ERBB4 IL16 TES MCM8 ZNF212 SH3BP2 ENTR1 TRPS1 MECOM ACY1 TRIM24 BCR TRIP4 INTS14 ZFHX4 UBR5 HPN MTR PARD3 | 1.30e-05 | 1116 | 190 | 19 | 31753913 | |
| Pubmed | 1.32e-05 | 9 | 190 | 3 | 18562307 | ||
| Pubmed | 1.34e-05 | 94 | 190 | 6 | 32062451 | ||
| Pubmed | HDAC5 TCF20 LRCH2 MARK3 R3HDM2 CSMD3 MAGI2 UBR5 PRRC2C KATNIP VCPIP1 | 1.65e-05 | 407 | 190 | 11 | 12693553 | |
| Pubmed | MARK3 ENTR1 MINK1 FNDC3A TRIM24 ANKLE2 TTK TRIP4 ITPR3 COL18A1 IARS2 PTPN13 UBR5 VPS13A MTR BOP1 MRPL41 MRPL3 MARK2 PARD3 ESPL1 OGA | 2.32e-05 | 1487 | 190 | 22 | 33957083 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TCF20 RAPH1 MINK1 NUP98 DAXX MYOF GTF2I BRAF RIMS1 MARK2 PARD3 ESPL1 OGA CDH17 VCPIP1 | 2.57e-05 | 774 | 190 | 15 | 15302935 |
| Pubmed | Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. | 2.97e-05 | 2 | 190 | 2 | 11959863 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 34354129 | ||
| Pubmed | Development of a highly efficient expression cDNA cloning system: application to oncogene isolation. | 2.97e-05 | 2 | 190 | 2 | 2052597 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 17767160 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 18071315 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 27210752 | ||
| Pubmed | Endophilin marks and controls a clathrin-independent endocytic pathway. | 2.97e-05 | 2 | 190 | 2 | 25517094 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 15792801 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 38755129 | ||
| Pubmed | [Expressions of cadherin molecules CDH18 and PCDH17 in human azoospermic testes]. | 2.97e-05 | 2 | 190 | 2 | 20180417 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 20733003 | ||
| Pubmed | Novel insights into cadherin processing by subtilisin-like convertases. | 2.97e-05 | 2 | 190 | 2 | 12586364 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 31004665 | ||
| Pubmed | Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7. | 2.97e-05 | 2 | 190 | 2 | 18988920 | |
| Pubmed | Low-copy piggyBac transposon mutagenesis in mice identifies genes driving melanoma. | 2.97e-05 | 2 | 190 | 2 | 24003131 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 22430208 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 17989107 | ||
| Pubmed | A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma. | 2.97e-05 | 2 | 190 | 2 | 28448514 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 19228595 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 18495154 | ||
| Pubmed | 3.42e-05 | 363 | 190 | 10 | 25036637 | ||
| Pubmed | 3.96e-05 | 35 | 190 | 4 | 33864728 | ||
| Pubmed | 4.11e-05 | 371 | 190 | 10 | 25241761 | ||
| Pubmed | PTEN identified as important risk factor of chronic obstructive pulmonary disease. | 4.40e-05 | 374 | 190 | 10 | 19625176 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | IL31RA MARK3 MINK1 SIK1 UPF3B BCR TTK MAP3K1 RTF1 MYOF BRAF IRAK3 BOP1 PARN MARK2 ESPL1 | 4.42e-05 | 910 | 190 | 16 | 36736316 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | EPS8L2 KALRN DSG3 MINK1 AKR1A1 ALDH1L1 ACY1 DYSF BCR SLC3A1 COL18A1 MYOF SIAE PTPN13 RAB43 CFAP70 MASP2 | 4.70e-05 | 1016 | 190 | 17 | 19056867 |
| Pubmed | 5.13e-05 | 381 | 190 | 10 | 18676680 | ||
| Pubmed | Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. | 5.25e-05 | 382 | 190 | 10 | 19170196 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | HDAC5 LRCH2 ENTR1 ANKLE2 CEP350 COL18A1 FRY GTF2I UBR5 PRRC2C MRPL41 MARK2 AGRN | 5.51e-05 | 639 | 190 | 13 | 23443559 |
| Pubmed | TES TCF20 ENTR1 MECOM FNDC3A BCR TRIP4 PCDH17 CEP350 TDRD3 IARS2 MTR ESPL1 VCPIP1 | 5.61e-05 | 733 | 190 | 14 | 34672954 | |
| Pubmed | 6.11e-05 | 39 | 190 | 4 | 22802532 | ||
| Pubmed | RAPH1 IFT57 ENTR1 MINK1 TRPS1 COPB2 NUP98 PPEF1 ANKLE2 ITPR3 CEP350 PTPDC1 TDRD3 PTPN13 VPS13A ALDH18A1 NHS | 6.94e-05 | 1049 | 190 | 17 | 27880917 | |
| Pubmed | TES RAPH1 NUP98 FNDC3A ANKLE2 TTK ITPR3 UBR5 PARP16 PRRC2C VPS13A VCPIP1 | 7.50e-05 | 568 | 190 | 12 | 37774976 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ACO2 NUP98 FNDC3A R3HDM2 UPF3B ANKLE2 TTK ITPR3 SPTBN5 TDRD3 IARS2 MIA2 NDUFAF7 VPS13A MTR BOP1 MRPL41 MRPL3 MARK2 ESPL1 VCPIP1 | 7.60e-05 | 1496 | 190 | 21 | 32877691 |
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 33378665 | ||
| Pubmed | Embryonic expression of three mouse genes with homology to the Drosophila melanogaster prickle gene. | 8.87e-05 | 3 | 190 | 2 | 14516664 | |
| Pubmed | Regulation of SIK1 abundance and stability is critical for myogenesis. | 8.87e-05 | 3 | 190 | 2 | 23256157 | |
| Pubmed | Analysis of the MRPL3, DNAJC13 and OFCC1 variants in Chinese Han patients with TS-CTD. | 8.87e-05 | 3 | 190 | 2 | 22507240 | |
| Pubmed | Oncogenic B-Raf(V600E) abrogates the AKT/B-Raf/Mps1 interaction in melanoma cells. | 8.87e-05 | 3 | 190 | 2 | 23726842 | |
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 37434585 | ||
| Pubmed | TRIM24 controls induction of latent HIV-1 by stimulating transcriptional elongation. | 8.87e-05 | 3 | 190 | 2 | 36690785 | |
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 32983173 | ||
| Pubmed | The proprotein convertase furin is a pro-oncogenic driver in KRAS and BRAF driven colorectal cancer. | 8.87e-05 | 3 | 190 | 2 | 32139876 | |
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 16396636 | ||
| Pubmed | The C2 domains of otoferlin, dysferlin, and myoferlin alter the packing of lipid bilayers. | 8.87e-05 | 3 | 190 | 2 | 23859474 | |
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 26071245 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 9486539 | ||
| Pubmed | Mink1 regulates β-catenin-independent Wnt signaling via Prickle phosphorylation. | 8.87e-05 | 3 | 190 | 2 | 22037766 | |
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 26087013 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 23108400 | ||
| Pubmed | [Clinical characteristics of childhood leukemia with EVI1 gene and BCR/ABL gene co-expression]. | 8.87e-05 | 3 | 190 | 2 | 24856998 | |
| Pubmed | Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis. | 8.87e-05 | 3 | 190 | 2 | 20483789 | |
| Pubmed | Replication of genetic variation in the MYO9B gene in Crohn's disease. | 8.87e-05 | 3 | 190 | 2 | 21515326 | |
| Pubmed | Th2 cells lacking T-bet suppress naive and memory T cell responses via IL-10. | 8.87e-05 | 3 | 190 | 2 | 33526653 | |
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 36263180 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 20096742 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 30026467 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 12837293 | ||
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 27568101 | ||
| Pubmed | T-bet is a new synergistic meeting point for the BCR and TLR9 signaling cascades. | 8.87e-05 | 3 | 190 | 2 | 24249581 | |
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 35328612 | ||
| Pubmed | Upregulation of the Na⁺-coupled phosphate cotransporters NaPi-IIa and NaPi-IIb by B-RAF. | 8.87e-05 | 3 | 190 | 2 | 24258620 | |
| Pubmed | TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer. | 8.87e-05 | 3 | 190 | 2 | 33282948 | |
| Pubmed | Stat3 inhibits PTPN13 expression in squamous cell lung carcinoma through recruitment of HDAC5. | 8.87e-05 | 3 | 190 | 2 | 24191246 | |
| Pubmed | Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity. | 8.87e-05 | 3 | 190 | 2 | 24177035 | |
| Pubmed | PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. | 8.87e-05 | 3 | 190 | 2 | 11433294 | |
| Pubmed | 8.87e-05 | 3 | 190 | 2 | 19103880 | ||
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 8.89e-05 | 190 | 190 | 7 | 15161933 | |
| Pubmed | SH3BP2 TRPS1 DAXX SPTBN5 PRDM11 DNAH12 PIK3C3 NDUFAF7 CD74 BOP1 CFAP70 | 9.80e-05 | 496 | 190 | 11 | 31343991 | |
| Pubmed | 9.88e-05 | 134 | 190 | 6 | 24324551 | ||
| Pubmed | AMPD2 RASA2 ZNF212 COPB2 SPPL2B ANKLE2 COL18A1 SIAE INTS14 PTPN13 BRAF PAN2 DDX3Y BOP1 PARD3 ESPL1 AGRN | 1.03e-04 | 1084 | 190 | 17 | 11544199 | |
| Pubmed | 1.03e-04 | 17 | 190 | 3 | 22153077 | ||
| Pubmed | 1.07e-04 | 263 | 190 | 8 | 34702444 | ||
| Pubmed | AMPD2 KALRN NUP98 ANKLE2 GTF2I BRAF PAN2 NHS BOP1 PARN MARK2 | 1.11e-04 | 503 | 190 | 11 | 16964243 | |
| Pubmed | Genetic susceptibility to distinct bladder cancer subphenotypes. | 1.17e-04 | 421 | 190 | 10 | 19692168 | |
| GeneFamily | Dyneins, axonemal | 6.00e-06 | 17 | 132 | 4 | 536 | |
| GeneFamily | Ferlin family | 7.49e-06 | 6 | 132 | 3 | 828 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 6.88e-04 | 24 | 132 | 3 | 654 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MARK3 SHB NUP98 MECOM FNDC3A R3HDM2 TRIM24 ANKLE2 TTK CEP350 MYOF TDRD3 PTPN13 MIA2 UBR5 PIK3C3 PRRC2C VPS13A MTR PARN PARD3 ZBTB11 SMAD7 | 6.45e-08 | 856 | 189 | 23 | M4500 |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN | 2.06e-06 | 200 | 189 | 10 | M9341 | |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN | 1.57e-05 | 200 | 189 | 9 | M8648 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | CHL1 BNC2 RALGDS FAT4 ERBB4 TES KALRN CHGA CSMD3 NECAP1 FRY ZFHX4 SRGAP1 CHSY3 RIMS1 | 2.39e-05 | 584 | 189 | 15 | M39068 |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-IIint.Bl, CD115+ B220- CD43- Ly6C- MHCIIint, Blood, avg-5 | MYO1G HFE HGF IL31RA SH3BP2 TRPS1 GAPT DGKG SIK1 CD83 NOD1 DNAH12 CSF1R DPEP2 CD74 IRAK3 MAP3K15 | 1.01e-07 | 400 | 187 | 17 | GSM605886_500 |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II-.Bl, CD115+ B220- CD43- Ly6C- MHCII-, Blood, avg-3 | MYO1G HFE HGF IL31RA SH3BP2 TRPS1 GAPT DGKG SIK1 CD83 NOD1 DNAH12 CSF1R DPEP2 CD74 IRAK3 MAP3K15 | 1.09e-07 | 402 | 187 | 17 | GSM605883_500 |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II+.Bl, CD115+ B220- CD43+ Ly6C+ MHCIIint, Blood, avg-4 | HFE SH3BP2 TRPS1 GAPT DGKG MYOF NOD1 CSF1R ABCA6 DPEP2 IFI30 CD74 IRAK3 MAP3K15 | 1.64e-05 | 408 | 187 | 14 | GSM605868_500 |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II-.BM, B220neg CD3neg CD115+ Ly-6C/Glo CD43+, Bone marrow, avg-3 | MYO1G HFE SH3BP2 GAPT DGKG SIK1 CD83 NOD1 DNAH12 CSF1R DPEP2 IFI30 CD74 IRAK3 | 1.69e-05 | 409 | 187 | 14 | GSM854332_500 |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-2 | HFE MINK1 TBX21 TRPS1 SIK1 CD83 NOD1 CSF1R RAB43 IFI30 CD74 KATNIP ACKR1 | 3.06e-05 | 376 | 187 | 13 | GSM538266_500 |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | ERBB4 EPS8L2 IFT57 SLC34A2 MECOM PTPN13 LIPH RP1 PARD3 ARHGAP8 DNAH11 | 5.42e-10 | 188 | 189 | 11 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | DYNLT2B NEK10 TTC21A DNAH2 DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 DNAH11 | 6.07e-10 | 190 | 189 | 11 | 169e600e95878000acf5d11f813f9028c7249646 |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | DYNLT2B NEK10 TTC21A DNAH2 DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 DNAH11 | 6.07e-10 | 190 | 189 | 11 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | CHL1 DNAH2 SLC34A2 MECOM LAMC2 IRX3 DNAH7 DNAH12 GAS2L2 RP1 DNAH11 | 6.42e-10 | 191 | 189 | 11 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | CHL1 DNAH2 SLC34A2 MECOM LAMC2 IRX3 DNAH7 DNAH12 GAS2L2 RP1 DNAH11 | 6.42e-10 | 191 | 189 | 11 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | CHL1 NEK10 TTC21A DNAH2 IRX3 DNAH7 EFHC1 RP1 CFAP70 ALOX15 DNAH11 | 7.17e-10 | 193 | 189 | 11 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | ERBB4 NEK10 SLC34A2 DNAH7 EVA1C DNAH12 LIPH RP1 CFAP70 PARD3 DNAH11 | 7.99e-10 | 195 | 189 | 11 | fce0c29574bb7aab181b9c00feb42681e285d1f2 |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | ERBB4 NEK10 SLC34A2 DNAH7 EVA1C DNAH12 LIPH RP1 CFAP70 PARD3 DNAH11 | 7.99e-10 | 195 | 189 | 11 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IFT57 NEK10 TTC21A DNAH2 DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 DNAH11 | 7.99e-10 | 195 | 189 | 11 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IFT57 NEK10 TTC21A DNAH2 DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 DNAH11 | 7.99e-10 | 195 | 189 | 11 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IFT57 NEK10 TTC21A DNAH2 DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 DNAH11 | 7.99e-10 | 195 | 189 | 11 | 3e70ee987d66d450062d5df3d7c733ccc7344470 |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | NEK10 DNAH2 SLC34A2 LAMC2 IRX3 DNAH7 DNAH12 RP1 CFAP70 ALOX15 DNAH11 | 8.90e-10 | 197 | 189 | 11 | 18fd7344628a87d5c7ef5efb66e260a4136245bf |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CHL1 ERBB4 EPS8L2 SLC34A2 LAMC2 IRX3 IRX1 ITPR3 COL18A1 LIPH AGRN | 9.91e-10 | 199 | 189 | 11 | 2e7f517c0444b4f29ff11c26ab32e9cc0f7e99ef |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-09 | 168 | 189 | 10 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-09 | 168 | 189 | 10 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | LPS-antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-09 | 178 | 189 | 10 | 289d1425c4e57fabcca994b27f9af1c0ce5d5bec | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | ERBB4 EPS8L2 MECOM PCDH17 PTPN13 LIPH CHSY3 RP1 PARD3 RNF145 | 4.98e-09 | 178 | 189 | 10 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NEK10 TTC21A DNAH2 DNAH7 EFHC1 DNAH12 GAS2L2 RP1 CFAP70 DNAH11 | 4.98e-09 | 178 | 189 | 10 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | ERBB4 EPS8L2 IFT57 MECOM PCDH17 PTPN13 LIPH CHSY3 RP1 RNF145 | 6.84e-09 | 184 | 189 | 10 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | ERBB4 SLC34A2 MECOM PTPN13 LIPH RP1 RIMS1 PARD3 ARHGAP8 RNF145 | 7.21e-09 | 185 | 189 | 10 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ERBB4 NEK10 TTC21A DNAH2 DNAH7 DNAH12 GAS2L2 RP1 CFAP70 DNAH11 | 7.21e-09 | 185 | 189 | 10 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | DYNLT2B NEK10 DNAH2 DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 DNAH11 | 7.21e-09 | 185 | 189 | 10 | f012c243343e1d1956db19b34d062e9b13de2b2a |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | DYNLT2B NEK10 TTC21A DNAH2 DNAH7 EFHC1 DNAH12 CFAP70 ALOX15 DNAH11 | 8.41e-09 | 188 | 189 | 10 | 606907c865bd2f11bb6474932716550f7723d858 |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-F_(Ciliated)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | DYNLT2B NEK10 TTC21A DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 DNAH11 | 8.41e-09 | 188 | 189 | 10 | 5ba5cbb403518026e9040379fb5d99339ea977d8 |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | DYNLT2B NEK10 TTC21A DNAH2 DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 | 8.85e-09 | 189 | 189 | 10 | 57ab947b81dbd9d3e896be89e28c4a62cf720837 |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | DYNLT2B NEK10 TTC21A DNAH2 DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 | 8.85e-09 | 189 | 189 | 10 | ebc16b8eab84167d74446783d7e802acedc6b9c6 |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | DYNLT2B NEK10 DNAH2 DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 DNAH11 | 9.31e-09 | 190 | 189 | 10 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|normal_Lung / Location, Cell class and cell subclass | DYNLT2B NEK10 DNAH2 DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 DNAH11 | 1.03e-08 | 192 | 189 | 10 | 097a13121820ab4e5cd2365600efccf5ea4ce8c3 |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | NEK10 TTC21A DNAH2 DNAH7 EFHC1 DNAH12 LIPH ENPP5 CFAP70 DNAH11 | 1.03e-08 | 192 | 189 | 10 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-08 | 193 | 189 | 10 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-08 | 193 | 189 | 10 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ERBB4 EPS8L2 MECOM DNAH7 SLC3A1 COL18A1 PTPN13 HPN NHS PARD3 | 1.14e-08 | 194 | 189 | 10 | 5eaaa81f4b2535f983c424aaef00077089526a5c |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | NEK10 DNAH2 IRX3 DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 DNAH11 | 1.14e-08 | 194 | 189 | 10 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.19e-08 | 195 | 189 | 10 | 0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NEK10 TTC21A DNAH7 EFHC1 DNAH12 GAS2L2 RP1 CFAP70 ALOX15 DNAH11 | 1.19e-08 | 195 | 189 | 10 | 79dc031258579ea328181dda33710dd897f1064a |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 1.25e-08 | 196 | 189 | 10 | af9e8f5ef9d03862f707e105857309b55595b1b9 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | ERBB4 NEK10 SLC34A2 DNAH7 DNAH12 LIPH RP1 CFAP70 PARD3 DNAH11 | 1.25e-08 | 196 | 189 | 10 | 87d9881cfec461a5d89b688a83749b618c519485 |
| ToppCell | NS-critical-d_0-4-Epithelial-Ciliated-diff|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DYNLT2B IFT57 NEK10 ALDH1L1 DNAH7 EFHC1 DNAH12 RP1 ALOX15 DNAH11 | 1.31e-08 | 197 | 189 | 10 | 62e20ef825b92908d7732aa625dcff7b95ef6ca8 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NEK10 DNAH2 ALDH1L1 DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 DNAH11 | 1.31e-08 | 197 | 189 | 10 | 91637bdeab85024b5a02d1066f76cb803a2d6420 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NEK10 DNAH2 ALDH1L1 DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 DNAH11 | 1.31e-08 | 197 | 189 | 10 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NEK10 DNAH2 ALDH1L1 DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 DNAH11 | 1.31e-08 | 197 | 189 | 10 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NEK10 DNAH2 ALDH1L1 DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 DNAH11 | 1.31e-08 | 197 | 189 | 10 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CHL1 SLC9A9 DSG3 PRICKLE1 LAMC2 MYOF PTPN13 CDH7 ALOX15 SPINK5 | 1.45e-08 | 199 | 189 | 10 | 94a7867e800df352731796de8c24cba133c29622 |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.45e-08 | 199 | 189 | 10 | debdd7dba774d9ccff7effc3f4c132393d203dfa | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | DYNLT2B NEK10 DNAH2 DNAH7 EFHC1 DNAH12 RP1 CFAP70 ALOX15 DNAH11 | 1.52e-08 | 200 | 189 | 10 | 9ae434c78e08adf95da49c85616e3ca72d1227bf |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-08 | 200 | 189 | 10 | ae91dc047dc80560ba298d8d21a772154fa2775d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.78e-08 | 159 | 189 | 9 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 4.25e-08 | 167 | 189 | 9 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.71e-08 | 169 | 189 | 9 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.96e-08 | 170 | 189 | 9 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | Immune_cells-B_cell|Immune_cells / Lineage and Cell class | 5.48e-08 | 172 | 189 | 9 | b646894b691a99bf2742bd9da8e578dff0e87f1f | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.05e-08 | 174 | 189 | 9 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.68e-08 | 176 | 189 | 9 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.72e-08 | 179 | 189 | 9 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.10e-08 | 180 | 189 | 9 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.12e-07 | 187 | 189 | 9 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.17e-07 | 188 | 189 | 9 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-07 | 189 | 189 | 9 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Epithelial_cells-Ciliated_cells-A|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.28e-07 | 190 | 189 | 9 | 549d813a8f23b175875e53347928941f143e236c | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-07 | 190 | 189 | 9 | 17829f4de31b3d9e4d71ba4817d18842aa699773 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 1.28e-07 | 190 | 189 | 9 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.34e-07 | 191 | 189 | 9 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.34e-07 | 191 | 189 | 9 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-07 | 191 | 189 | 9 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-07 | 191 | 189 | 9 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-07 | 191 | 189 | 9 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-07 | 191 | 189 | 9 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.34e-07 | 191 | 189 | 9 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class （2021.01.30） | 1.34e-07 | 191 | 189 | 9 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-07 | 191 | 189 | 9 | dad675251e129254955eac179c84a641a4864586 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-07 | 191 | 189 | 9 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-07 | 191 | 189 | 9 | 6d2cf41ee946137c039ddcc13593fc3f670afbba | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.34e-07 | 191 | 189 | 9 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.40e-07 | 192 | 189 | 9 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | multiciliated|World / shred by cell class for turbinate | 1.40e-07 | 192 | 189 | 9 | 0f89ea0deb651ca11531c51ee94e0233608d22ea | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-07 | 193 | 189 | 9 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-07 | 193 | 189 | 9 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-07 | 194 | 189 | 9 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.53e-07 | 194 | 189 | 9 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.53e-07 | 194 | 189 | 9 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.53e-07 | 194 | 189 | 9 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-07 | 195 | 189 | 9 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.60e-07 | 195 | 189 | 9 | d673f8844896d5c7b76a7bc7f6b88a039f1bc263 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.60e-07 | 195 | 189 | 9 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.60e-07 | 195 | 189 | 9 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-07 | 195 | 189 | 9 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-07 | 195 | 189 | 9 | d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-07 | 195 | 189 | 9 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.60e-07 | 195 | 189 | 9 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.60e-07 | 195 | 189 | 9 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-07 | 195 | 189 | 9 | e7f069f557a59ee7b502ff82ad4c9f47fa619ba8 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 1.67e-07 | 196 | 189 | 9 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.67e-07 | 196 | 189 | 9 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | 11.5-Distal-Epithelial-Bud_tip_adjacent|Distal / Age, Tissue, Lineage and Cell class | 1.67e-07 | 196 | 189 | 9 | a6a242868df0d2ff30825624a8d7c0367527594d | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.67e-07 | 196 | 189 | 9 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|World / disease group, cell group and cell class | 1.75e-07 | 197 | 189 | 9 | 60fee75b12451206bb2c07b61651a73c59ec6ade | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-07 | 197 | 189 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.75e-07 | 197 | 189 | 9 | b7aff83c27606d87565382a768119a863fe1c294 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.75e-07 | 197 | 189 | 9 | 4ae08ccb6f1da626c4f0fb0140a2811cb6e31ba1 | |
| ToppCell | PCW_13-14-Epithelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.82e-07 | 198 | 189 | 9 | 48eb6f69a464a34ab32e8d425a22b9d45ec20428 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 8.74e-06 | 7 | 188 | 3 | DOID:11724 (implicated_via_orthology) | |
| Disease | Acute Myeloid Leukemia, M1 | 1.61e-05 | 125 | 188 | 7 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.61e-05 | 125 | 188 | 7 | C1879321 | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 2.03e-05 | 52 | 188 | 5 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | FEV/FEC ratio | BNC2 WWC3 SH3BP2 TRPS1 OFCC1 SHB ANKS1B DGKG MECOM LAMC2 R3HDM2 AKR1A1 MAP3K1 TG SPTBN5 EFHC1 GTF2I DNAH12 DPEP2 PARD3 SMAD7 | 4.03e-05 | 1228 | 188 | 21 | EFO_0004713 |
| Disease | Squamous cell carcinoma of lung | 4.99e-05 | 32 | 188 | 4 | C0149782 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 6.49e-05 | 66 | 188 | 5 | EFO_0003940, EFO_0004611 | |
| Disease | Leukemia, Myelocytic, Acute | 1.27e-04 | 173 | 188 | 7 | C0023467 | |
| Disease | Malignant neoplasm of breast | ERBB4 CATSPERE RAPH1 KALRN ACO2 NUP98 DGKG MECOM DTX3L ACY1 DYSF MAP3K1 CSF1R MIA2 BRAF MTR NHS CD74 | 1.88e-04 | 1074 | 188 | 18 | C0006142 |
| Disease | visual impairment and progressive phthisis bulbi (implicated_via_orthology) | 2.40e-04 | 4 | 188 | 2 | DOID:0070356 (implicated_via_orthology) | |
| Disease | glycoproteinosis (implicated_via_orthology) | 2.40e-04 | 4 | 188 | 2 | DOID:3343 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement | BNC2 DYNLT2B ERBB4 TES ENTR1 TRPS1 RTN4RL1 R3HDM2 PCDH17 MAP3K1 MSL2 GTF2I ABCA6 HPN SLC5A6 POC1B ACKR1 IL4R DNAH11 | 2.71e-04 | 1206 | 188 | 19 | EFO_0004458 |
| Disease | Autosomal Recessive Primary Microcephaly | 3.59e-04 | 22 | 188 | 3 | C3711387 | |
| Disease | apolipoprotein A 1 measurement | HFE HDAC5 TRPS1 DGKG FNDC3A R3HDM2 MSL2 ARG1 COL18A1 ABCA6 DPEP2 FURIN RNF145 CDH17 SMAD7 | 3.73e-04 | 848 | 188 | 15 | EFO_0004614 |
| Disease | IgE RESPONSIVENESS, ATOPIC | 3.99e-04 | 5 | 188 | 2 | C1840253 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.44e-04 | 152 | 188 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | non-high density lipoprotein cholesterol measurement | HFE BNC2 TRPS1 LAMC2 R3HDM2 DTX3L CSF1R ABCA6 POC1B RP1 MARK2 SMAD7 DNAH11 | 6.95e-04 | 713 | 188 | 13 | EFO_0005689 |
| Disease | multiple myeloma | 7.70e-04 | 112 | 188 | 5 | EFO_0001378 | |
| Disease | squamous cell carcinoma | 8.94e-04 | 67 | 188 | 4 | EFO_0000707 | |
| Disease | hair color | 9.02e-04 | 311 | 188 | 8 | EFO_0003924 | |
| Disease | diastolic blood pressure, alcohol drinking | 9.74e-04 | 118 | 188 | 5 | EFO_0004329, EFO_0006336 | |
| Disease | colorectal cancer (is_implicated_in) | 1.09e-03 | 121 | 188 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | microcephaly (implicated_via_orthology) | 1.10e-03 | 32 | 188 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | apolipoprotein B measurement | HFE BNC2 AMPD2 RAPH1 TBX21 TRPS1 R3HDM2 ABCA10 MYOF ABCA6 RP1 DNAH11 | 1.18e-03 | 663 | 188 | 12 | EFO_0004615 |
| Disease | PR interval | KALRN MARK3 ACO2 MINK1 ALDH1L1 DYSF MAGI2 SRGAP1 ALDH18A1 DNAH11 | 1.35e-03 | 495 | 188 | 10 | EFO_0004462 |
| Disease | HMG CoA reductase inhibitor use measurement | 1.38e-03 | 189 | 188 | 6 | EFO_0009932 | |
| Disease | corneodesmosin measurement | 1.41e-03 | 9 | 188 | 2 | EFO_0801499 | |
| Disease | lifestyle measurement, systolic blood pressure | 1.41e-03 | 9 | 188 | 2 | EFO_0006335, EFO_0010724 | |
| Disease | Unipolar Depression | 1.42e-03 | 259 | 188 | 7 | C0041696 | |
| Disease | Liver Cirrhosis, Experimental | HGF FMO1 TES TCF20 R3HDM2 ALDH1L1 CD83 DYSF TRIM24 BCR FRY CSF1R CD74 | 1.46e-03 | 774 | 188 | 13 | C0023893 |
| Disease | lung squamous cell carcinoma (is_marker_for) | 1.56e-03 | 36 | 188 | 3 | DOID:3907 (is_marker_for) | |
| Disease | Lung diseases | 1.58e-03 | 78 | 188 | 4 | C0024115 | |
| Disease | red blood cell density measurement | KALRN TRPS1 OFCC1 DNAH2 MECOM R3HDM2 IRX1 TG UBR5 DPEP2 RAB43 HSF2 SMAD7 PEAR1 | 1.60e-03 | 880 | 188 | 14 | EFO_0007978 |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 1.76e-03 | 10 | 188 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | interstitial lung disease (is_implicated_in) | 1.76e-03 | 10 | 188 | 2 | DOID:3082 (is_implicated_in) | |
| Disease | glycine measurement | 1.89e-03 | 137 | 188 | 5 | EFO_0009767 | |
| Disease | Colorectal Carcinoma | CHL1 RALGDS KALRN ALDH1L1 CSMD3 ABCA10 BRAF ABCA6 VPS13A PAN2 CDH7 SMAD7 | 1.91e-03 | 702 | 188 | 12 | C0009402 |
| Disease | short-term memory | 1.98e-03 | 83 | 188 | 4 | EFO_0004335 | |
| Disease | hair colour measurement | CHL1 BNC2 IL16 RASA2 MARK3 TRPS1 SHB SIK1 MAP3K1 POC1B PARD3 | 2.07e-03 | 615 | 188 | 11 | EFO_0007822 |
| Disease | cholesterol in very small VLDL measurement | 2.11e-03 | 40 | 188 | 3 | EFO_0022231 | |
| Disease | cervical cancer | 2.11e-03 | 40 | 188 | 3 | MONDO_0002974 | |
| Disease | Leukoencephalopathy | 2.14e-03 | 11 | 188 | 2 | C0270612 | |
| Disease | Neuroendocrine Tumors | 2.14e-03 | 11 | 188 | 2 | C0206754 | |
| Disease | breast carcinoma | HFE HORMAD2 AMPD2 ERBB4 MCM8 RASA2 NEK10 ACO2 TRPS1 AKR1A1 MAP3K1 GTF2I HSF2 RNF145 DNAH11 | 2.33e-03 | 1019 | 188 | 15 | EFO_0000305 |
| Disease | Abruptio Placentae | 2.56e-03 | 12 | 188 | 2 | EFO_1001754 | |
| Disease | waist-hip ratio, body mass index | 2.56e-03 | 12 | 188 | 2 | EFO_0004340, EFO_0004343 | |
| Disease | Myeloproliferative disease | 2.56e-03 | 12 | 188 | 2 | C0027022 | |
| Disease | cholesterol in medium VLDL measurement | 2.78e-03 | 44 | 188 | 3 | EFO_0022225 | |
| Disease | breast cancer (is_implicated_in) | 2.80e-03 | 150 | 188 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | total lipids in very small VLDL measurement | 2.97e-03 | 45 | 188 | 3 | EFO_0022156 | |
| Disease | disorder of pharynx | 3.16e-03 | 46 | 188 | 3 | MONDO_0020592 | |
| Disease | major depressive disorder | 3.22e-03 | 155 | 188 | 5 | MONDO_0002009 | |
| Disease | asthma | NEK10 ACO2 TBX21 MECOM DYSF CSMD3 RTF1 PRDM11 PIK3C3 FURIN IL4R SMAD7 | 3.30e-03 | 751 | 188 | 12 | MONDO_0004979 |
| Disease | Non-Small Cell Lung Carcinoma | 3.31e-03 | 156 | 188 | 5 | C0007131 | |
| Disease | free cholesterol in small VLDL measurement | 3.36e-03 | 47 | 188 | 3 | EFO_0022272 | |
| Disease | free cholesterol in very small VLDL measurement | 3.36e-03 | 47 | 188 | 3 | EFO_0022275 | |
| Disease | free cholesterol in medium VLDL measurement | 3.36e-03 | 47 | 188 | 3 | EFO_0022269 | |
| Disease | Primary Ciliary Dyskinesia | 3.36e-03 | 47 | 188 | 3 | C4551720 | |
| Disease | Adenocarcinoma of large intestine | 3.36e-03 | 96 | 188 | 4 | C1319315 | |
| Disease | testosterone measurement | HFE HORMAD2 HGF SPEM3 IQSEC2 TRPS1 DNAH2 ANKS1B MECOM R3HDM2 IRX1 CSMD3 MSL2 GTF2I ZFHX4 HPN MUCL3 | 3.38e-03 | 1275 | 188 | 17 | EFO_0004908 |
| Disease | asthma (is_implicated_in) | 3.40e-03 | 157 | 188 | 5 | DOID:2841 (is_implicated_in) | |
| Disease | Childhood Ataxia with Central Nervous System Hypomyelinization | 3.49e-03 | 14 | 188 | 2 | C1858991 | |
| Disease | actinic keratosis | 3.49e-03 | 14 | 188 | 2 | EFO_0002496 | |
| Disease | neuroticism measurement, cognitive function measurement | 3.56e-03 | 566 | 188 | 10 | EFO_0007660, EFO_0008354 | |
| Disease | smoking status measurement, diastolic blood pressure | 3.59e-03 | 159 | 188 | 5 | EFO_0006336, EFO_0006527 | |
| Disease | mean arterial pressure, alcohol drinking | 3.62e-03 | 98 | 188 | 4 | EFO_0004329, EFO_0006340 | |
| Disease | Bipolar Disorder | 3.66e-03 | 477 | 188 | 9 | C0005586 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 3.78e-03 | 49 | 188 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Eczema | 3.86e-03 | 310 | 188 | 7 | HP_0000964 | |
| Disease | visceral adipose tissue measurement | 3.87e-03 | 481 | 188 | 9 | EFO_0004765 | |
| Disease | bipolar disorder | DOCK2 HDAC5 TCF20 OFCC1 ANKS1B RTN4RL1 SIAE BRAF FURIN RIMS1 | 4.07e-03 | 577 | 188 | 10 | MONDO_0004985 |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 4.17e-03 | 102 | 188 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | phospholipids in very small VLDL measurement | 4.23e-03 | 51 | 188 | 3 | EFO_0022300 | |
| Disease | leprosy | 4.32e-03 | 103 | 188 | 4 | EFO_0001054 | |
| Disease | phospholipids in IDL measurement | 4.47e-03 | 52 | 188 | 3 | EFO_0022164 | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 4.57e-03 | 16 | 188 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | cholesterol in small VLDL measurement | 4.72e-03 | 53 | 188 | 3 | EFO_0022228 | |
| Disease | Major Depressive Disorder | 4.79e-03 | 243 | 188 | 6 | C1269683 | |
| Disease | serum albumin measurement | 4.86e-03 | 592 | 188 | 10 | EFO_0004535 | |
| Disease | Metastatic melanoma | 4.97e-03 | 54 | 188 | 3 | C0278883 | |
| Disease | eosinophil measurement | 5.11e-03 | 108 | 188 | 4 | EFO_0803540 | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 5.16e-03 | 17 | 188 | 2 | C1839839 | |
| Disease | Benign neoplasm of stomach | 5.16e-03 | 17 | 188 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 5.16e-03 | 17 | 188 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 5.16e-03 | 17 | 188 | 2 | C0154060 | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 5.24e-03 | 55 | 188 | 3 | DOID:9952 (is_implicated_in) | |
| Disease | intraocular pressure measurement | 5.56e-03 | 509 | 188 | 9 | EFO_0004695 | |
| Disease | comparative body size at age 10, self-reported | 5.71e-03 | 420 | 188 | 8 | EFO_0009819 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 5.78e-03 | 18 | 188 | 2 | EFO_1000649, HP_0000131 | |
| Disease | Adrenocortical carcinoma | 5.78e-03 | 18 | 188 | 2 | C0206686 | |
| Disease | age at onset, Parkinson disease | 5.78e-03 | 18 | 188 | 2 | EFO_0004847, MONDO_0005180 | |
| Disease | obsolete_red blood cell distribution width | HFE RALGDS KALRN MARK3 ENTR1 MECOM R3HDM2 IRX1 MAP3K1 GTF2I ABCA6 PRRC2C VPS13A CHSY3 RP1 CDH18 SMAD7 | 5.80e-03 | 1347 | 188 | 17 | EFO_0005192 |
| Disease | alcohol consumption measurement | HORMAD2 RASA2 RAPH1 MARK3 ACO2 TRPS1 DNAH2 ANKS1B LAMC2 CSMD3 SPTBN5 MAGI2 DPEP2 PARD3 AGRN CDH18 | 6.11e-03 | 1242 | 188 | 16 | EFO_0007878 |
| Disease | hepatocellular carcinoma (is_implicated_in) | 6.19e-03 | 181 | 188 | 5 | DOID:684 (is_implicated_in) | |
| Disease | allergic disease | 6.37e-03 | 258 | 188 | 6 | MONDO_0005271 | |
| Disease | multiple myeloma (is_implicated_in) | 6.37e-03 | 59 | 188 | 3 | DOID:9538 (is_implicated_in) | |
| Disease | antihyperlipidemic drug use measurement | 6.37e-03 | 115 | 188 | 4 | EFO_0803367 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELPKGEFDPGQDTYQ | 531 | Q99798 | |
| QFGDVGFNPYEPAVD | 211 | Q14137 | |
| ASNGPPKAEDEYVNE | 1191 | Q15303 | |
| DKFGGEHNPPSIYLE | 66 | P15056 | |
| DFGYSVGLNPPEEEA | 156 | Q86XL3 | |
| PPINRTDYSGDGKNG | 1171 | Q4VNC0 | |
| GKPGDLNQPYEIINS | 841 | Q5SY80 | |
| DPGIPQFGYKISDQG | 1356 | Q7Z407 | |
| DNYLSGVIFPDPSGD | 291 | Q8WWZ4 | |
| SLNYGSPQKFSPEGD | 811 | Q6ZN30 | |
| GQPGADAEKPFYVNV | 166 | P11274 | |
| PTEYENLFPGLKEAF | 791 | P35606 | |
| NDEKPVFSQPEGYDV | 576 | Q6V0I7 | |
| PVQYFAHIKENEPGG | 691 | Q6V0I7 | |
| SDDYFEPVAPEFQGK | 461 | Q8N139 | |
| FKATSPRGEPQDGLY | 471 | P78314 | |
| LNLKEPLYVGGAPDF | 1761 | O00468 | |
| NPGYAGRTELPENLK | 1996 | Q96DT5 | |
| FPDGDYGANLEAAAP | 36 | Q16570 | |
| LGPNYTKEGPEGNDI | 816 | Q01433 | |
| IQKAEDPSQPDSAGY | 51 | Q53RE8 | |
| NKPGPDTFPDYGDVL | 276 | Q9UER7 | |
| DVKDYGDLPFADIPN | 46 | P05089 | |
| DQRGQKPGDLYSPDS | 736 | Q9Y2K5 | |
| SKAGAGKQAPELPDY | 366 | Q86UN2 | |
| PGLVDLPKENFEASY | 91 | Q9H4I0 | |
| PPELLSDQQKAGYGG | 1206 | Q70E73 | |
| PGGSVPFKLEENYDN | 406 | O14917 | |
| GTIAVYQGPQKEPDD | 781 | Q15283 | |
| PGPGDPDEQYDFLFK | 6 | Q86YS6 | |
| GFLHPPGEKSSENYQ | 1156 | Q14573 | |
| NPPKVESAEGFPSYD | 356 | O95453 | |
| FGPYVGEQRSNLKDP | 106 | Q03112 | |
| KGQNGSFDAPNERPY | 76 | Q01151 | |
| QDDNDPPKEYDPGQF | 591 | Q7Z6G8 | |
| EGKEVQPPSKDSGYG | 866 | P32926 | |
| QGPVGDPDKYRLSQD | 256 | Q9NPA2 | |
| QGPNEGIPFIDDYIS | 1016 | Q504Q3 | |
| VYLDDNQKPPVGEGL | 801 | P52948 | |
| AENGQFPYLGEVKPG | 36 | Q86UL8 | |
| EGNGFSYTIEDPALP | 521 | Q8NEM0 | |
| NSKGAGPESEPYIFQ | 896 | O00533 | |
| GEIQSFPLPDGKYSL | 246 | Q9UJA3 | |
| GNIYPGNDTFDIDPE | 166 | Q8TDD5 | |
| SIQAYAKEGVPSEGP | 411 | Q8NI17 | |
| SLPYPVDDGRGKAQF | 321 | Q9NVR5 | |
| PRENDPVHGADGKFY | 931 | Q9NQ38 | |
| TPHDYQPLGFKEGVN | 191 | Q8N7B1 | |
| DAGGDFKIPVLPYGQ | 961 | O60303 | |
| QNPAYFEGKPASLDE | 401 | Q5JU85 | |
| ADLPPEGFQASYGKD | 861 | Q6ZWH5 | |
| AAFPPDVGGNVDYKN | 141 | Q96A32 | |
| NGPGPFYNKGLISEE | 896 | Q5VY43 | |
| DPDVGLAYVFGPDAN | 476 | P39060 | |
| LPGSVKPAEYDQEGS | 416 | Q9UJA9 | |
| DNYENVEAGPPKAKG | 91 | Q8N292 | |
| YPDPFEISLAQGKEG | 41 | Q14005 | |
| GSPGFEYHQPGDKFE | 2296 | O60229 | |
| NPGYAGRSELPDNLK | 1356 | Q6ZR08 | |
| LPELGPGGDQQSYEF | 501 | Q9Y239 | |
| VGQHEEEYFSGPEPK | 606 | P16050 | |
| PLGNIDFYPNGGLDQ | 216 | Q8WWY8 | |
| PDKGFDDNYCRNPDG | 251 | P14210 | |
| PSEKSYQEGGFPNIL | 111 | Q9Y616 | |
| PEFDGYEPGEVVKQA | 486 | Q32M88 | |
| PDKGEEACGYFLNPS | 381 | Q8TC44 | |
| GNPLEQESGFTYLPE | 131 | A2A3K4 | |
| FEPKDVLPNGDGTYQ | 251 | Q30201 | |
| VPNQVDFPGSEYAEG | 186 | Q8IWF2 | |
| LVLNYDPGDPKAFTE | 16 | Q9HCI7 | |
| PEDAGAPFEQAGQKY | 551 | Q9H6S3 | |
| GGYLPFRDPNSEENS | 241 | P05981 | |
| PGSDDAKLIDIFYPG | 276 | P54886 | |
| EGGDIPPKYFVVTNN | 246 | Q8N5Y8 | |
| GKPLPGATNEEVYNI | 661 | Q86UR5 | |
| FRLPASAEPKGNEYG | 76 | Q8IZS5 | |
| DSEEEGYFLGQPIPQ | 771 | Q96MT3 | |
| DNKGQEYPAIVEFAP | 121 | Q9BZI7 | |
| NEGGSLKQYDPHEPI | 36 | P49619 | |
| QKDGEYGINFDPSGS | 281 | P58658 | |
| PPGQLNGYQEKEPSE | 471 | Q711Q0 | |
| SLSPGQDPEGGVDYK | 686 | P07333 | |
| KEYGASPVLSQGVDP | 1931 | Q14674 | |
| SGEEGYKPFQDLIPG | 626 | P24394 | |
| NKAGRPFEQPQEYDD | 96 | Q9NWB7 | |
| IPKYTGPGDASNFDD | 316 | P22612 | |
| KNPRLGDFYGDPQSS | 21 | Q0VDD7 | |
| TSAPGDDVKNAPGQY | 1391 | Q92608 | |
| PGIQRTAYLPDNKEG | 656 | Q8TDB6 | |
| ALDFFGNGPPVNYKT | 31 | P13284 | |
| GLEYQQPFFEDPTGA | 156 | Q96C92 | |
| NNIPDAFIVGGPYEE | 241 | Q5T0N1 | |
| EPGGPYDKAIQELAQ | 646 | Q8NHY3 | |
| DPPKDNGGATINKYV | 586 | Q9Y2H6 | |
| PDLAGNYDPGASFDV | 161 | P09958 | |
| IQPNDGPVFYKVDGQ | 16 | Q96F85 | |
| PLDSFPGINAFKGQY | 156 | Q01740 | |
| KENPYGEDDNKSPFP | 376 | Q96SY0 | |
| NPGYAGRSELPDNLK | 1431 | Q8WXX0 | |
| EQAKFYAPEAAAGPE | 96 | P35452 | |
| LDKPEGNNNGTYDGI | 2531 | Q5VT06 | |
| PYSDEDGGPQDQLKN | 181 | Q12967 | |
| AAPELFQGKKYDGPE | 216 | Q7KZI7 | |
| PELFQGKKYDGPEVD | 221 | P27448 | |
| ASPGFPGEYANDQER | 31 | O00187 | |
| DINDNAPKFTDGPYI | 151 | Q13634 | |
| LPPYNGFGLVEDSAQ | 381 | Q5JVL4 | |
| DYDGAGKFPQGLEDV | 351 | Q9H4A9 | |
| PGKPAGQQSDYAVSE | 1561 | Q9ULL0 | |
| DQCKAGYFGDPLAPN | 551 | Q13753 | |
| GGSYDEDKNDPISPY | 1581 | Q5TBA9 | |
| GSFRPKCDENGNYLP | 226 | P04233 | |
| INDNEPKFLDGPYTA | 146 | Q9ULB5 | |
| EPGAGYKKLFSDAQP | 621 | Q9UQL6 | |
| GGNTGINFEKYDDIP | 151 | O15523 | |
| QGLPEGVAFKHPENY | 151 | P78347 | |
| PGKPFLYVNATDLDD | 141 | Q12864 | |
| NPGYAGRTELPENLK | 1906 | Q9P225 | |
| PDPYTELNTGKGEGV | 536 | O75923 | |
| KEQGDPAPGVQGYSV | 36 | Q9NPB3 | |
| PEAEKNAGEPENTYI | 16 | Q8WW35 | |
| DFYPNKNHGPDSGIG | 336 | Q5VUJ6 | |
| GADYEVPQSQPIKLG | 111 | Q12923 | |
| YNDAEDEGGPNSYPV | 486 | Q3MIW9 | |
| DSGPNAEINYLLGPD | 526 | Q9BZA8 | |
| PGEGFQSAKENPRYS | 1246 | Q8TEW0 | |
| DGPVEFQHPYFKQGQ | 86 | Q03933 | |
| FPQLGAQYELKDSPG | 86 | P78415 | |
| KNGLPSERNPYVFNG | 186 | O14829 | |
| AAGREPFKPGNYDIQ | 221 | P56715 | |
| ESENGAYLDNPPKGA | 906 | Q96PC5 | |
| YGAFIKKSPPGNDDQ | 86 | Q8N4C8 | |
| GKNLPFPTYFPDGDE | 311 | P09001 | |
| GDSPDNKYRVFIGPQ | 331 | Q13233 | |
| NPAGPYGQRTDKELI | 1231 | Q6ZN16 | |
| NAKYGSGVLPDAPKE | 621 | Q92541 | |
| PDNLEKYGFEPTQEG | 111 | Q8IXM3 | |
| PKEKQPVAGSEGAQY | 131 | Q9UGI8 | |
| AQKERDFEDPYNGPG | 86 | Q15464 | |
| DFEDPYNGPGSSLRK | 91 | Q15464 | |
| SGQYTGFNDHKPLDP | 941 | Q7Z6B7 | |
| AEAKENPLPQGSVDY | 421 | Q9H7E2 | |
| ASPQTPGKENIYEGD | 611 | Q8IVB4 | |
| FLQYPEGEGQKDVLP | 741 | A0AVI2 | |
| QYGPGPDETLEQVQK | 1291 | Q6T4R5 | |
| GKYFSSGNEPAENPV | 26 | Q7L592 | |
| YDDGVGLPFQSQPDL | 736 | O60502 | |
| YGQDHLDTGLFPEKP | 586 | Q9Y289 | |
| GQFQYGDPGRPKNAT | 121 | P78414 | |
| KYAPSENGPNGISAE | 706 | Q8NEB9 | |
| PYKRGFDEGDVHPQA | 316 | Q9NQV5 | |
| PNAGLPNTFGDYDET | 286 | Q99707 | |
| YPGAKDQRQGSLLPE | 646 | Q8TE76 | |
| VSGIPYGQPKQENDF | 246 | Q99519 | |
| EKETNDDNYGPGPSL | 156 | Q9Y520 | |
| APEVFEGKEYEGPQL | 191 | A0A0B4J2F2 | |
| APEVFEGKEYEGPQL | 191 | P57059 | |
| AYGEKNLTFEGPLPE | 396 | Q9HAT2 | |
| ILGSQEPDFKGVQPY | 51 | Q07837 | |
| GGQDQSKEPPYGADV | 681 | Q9NSE4 | |
| KVEEPGYAESQPLQG | 1061 | Q9NRC6 | |
| GDNPFPKNADGTICY | 121 | P14550 | |
| LPQPEEGATYEGIQK | 191 | O75891 | |
| QPKPDYGAAVAFFEE | 26 | Q03154 | |
| SQKYPGPQAEGDSEG | 191 | P10645 | |
| DPKVTNGGNPPTDDY | 751 | Q70JA7 | |
| NGGNPPTDDYFIFSK | 756 | Q70JA7 | |
| ELGDAQPNPDKYLEG | 6 | O95436 | |
| KYLEGAAGQQPTAPD | 16 | O95436 | |
| APAGGEKSGALPQQY | 856 | Q9UHF7 | |
| EKSGALPQQYPASGE | 861 | Q9UHF7 | |
| RIKQENSGPPENYDF | 721 | O15164 | |
| YDPSKEENRPVGGFS | 281 | Q9NYT0 | |
| EPSLDIFYDLPQGNG | 281 | O15105 | |
| APPAEAGYDQNKTDF | 2741 | Q86UP3 | |
| NEREPYAPGTEGNVK | 16 | O95625 | |
| EPYQGAIQGPEEFVE | 2886 | Q96RL7 | |
| TEDSGSQKGPYVPQD | 861 | A0A1B0GUW6 | |
| EKGPGYPQAEALLAE | 81 | Q99962 | |
| ERLVPPGGNKTQYDE | 121 | Q8TCT7 | |
| VSGFPQYPTGQEKGD | 721 | Q9UGU0 | |
| QGIPLGSEYFEKLDP | 441 | Q8NDW8 | |
| DGKEYDNLPEAFPIT | 581 | Q96JH7 | |
| PGFEQERHPGDSKNY | 226 | Q9H832 | |
| GKPVNFDDYGDIHIP | 281 | P85298 | |
| EALPPDKYGQNESFA | 96 | P33981 | |
| QYTQEGPADLPGEFS | 221 | Q9UDV6 | |
| LRGKDVEFPNDYPSG | 491 | Q15650 | |
| LVPYPEKSSEDGVGN | 86 | Q96LX8 | |
| LLQENVPSYEKDPGF | 361 | Q5H8A4 | |
| RPDNQEGAFDPKEYP | 636 | Q96MT1 | |
| PDFVPRAGGENYKEF | 2686 | P01266 | |
| GAPSPFDKEAEGQFY | 516 | Q9UL17 | |
| GLPQYEKPDAEGSQL | 396 | Q9ULE0 | |
| DDGDDNAPLFYQPGK | 2496 | O95071 | |
| GPEYGKPDFVLLDQV | 6 | B0I1T2 | |
| FPDPYDELNTGKGEG | 516 | Q9NZM1 | |
| GELFAQAPVEQYPGI | 66 | Q8NC96 |